Alector, Inc. (NASDAQ:ALEC) Receives $4.00 Average Price Target from Analysts

Shares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have been given an average recommendation of "Hold" by the seven brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $4.00.

A number of research firms have recently issued reports on ALEC. Morgan Stanley reissued an "underweight" rating and issued a $1.50 price target (down from $3.00) on shares of Alector in a research note on Friday, March 7th. HC Wainwright boosted their price target on shares of Alector from $7.00 to $10.00 and gave the company a "buy" rating in a research note on Friday, May 9th.

Institutional Investors Weigh In On Alector

Large investors have recently modified their holdings of the company. Squarepoint Ops LLC purchased a new stake in shares of Alector in the 4th quarter valued at approximately $25,000. Tema Etfs LLC purchased a new stake in shares of Alector in the 4th quarter valued at approximately $27,000. Tower Research Capital LLC TRC increased its position in shares of Alector by 71.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 14,670 shares of the company's stock valued at $28,000 after purchasing an additional 6,096 shares during the last quarter. CWM LLC boosted its holdings in shares of Alector by 370.7% in the 1st quarter. CWM LLC now owns 33,643 shares of the company's stock valued at $41,000 after buying an additional 26,495 shares in the last quarter. Finally, Vontobel Holding Ltd. boosted its holdings in shares of Alector by 127.3% in the 4th quarter. Vontobel Holding Ltd. now owns 25,000 shares of the company's stock valued at $47,000 after buying an additional 14,000 shares in the last quarter. 85.83% of the stock is owned by hedge funds and other institutional investors.

Alector Stock Down 4.9%

NASDAQ:ALEC traded down $0.08 on Friday, hitting $1.54. The stock had a trading volume of 408,838 shares, compared to its average volume of 848,177. The company has a fifty day moving average price of $1.21 and a two-hundred day moving average price of $1.53. The stock has a market cap of $153.99 million, a price-to-earnings ratio of -0.91 and a beta of 0.71. Alector has a 1-year low of $0.87 and a 1-year high of $6.78.

Alector Company Profile

Alector, Inc, a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.